A Microfluidic Device And A Method For Generating A Mixed Biological Microenvironment
Patent Information
- Application Number
- IN202541132111
- Authority / Receiving Office
- IN · IN
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2025-12-26
- Publication Date
- 2026-10-26
- Estimated Expiration
- 2045-12-26
AI Technical Summary
Existing microfluidic systems struggle to create realistic biological microenvironments for disease modeling due to limitations in passive mixing, long-term cell culture support, independent flow regulation, and compatibility with shear-sensitive cells, lacking integrated observation and therapeutic delivery capabilities.
A microfluidic device with a first chamber, serpentine microchannel, and second chamber, featuring internal geometrical features for passive mixing, independent flow regulation, and surface modifications for long-term culture, using PDMS bonded to a rigid substrate, enabling controlled interaction of multiple biological components and therapeutic delivery.
Enables efficient passive mixing of biological components under low-shear conditions, supports long-term cell culture, and allows precise control over component proportions and therapeutic administration, facilitating disease modeling and therapeutic screening.
Abstract
Description
FIELD OF THE INVENTION
[001] The present disclosure relates to microfluidic technologies, and, more particularly, to amicrofluidic device configured for generating a mixed biological microenvironment throughpassive mixing of multiple biological or biochemical components within a microchannelhaving internal geometrical features and delivering the mixed components to a downstreamchamber for cellular interaction, co-culture, or disease-modeling applications, and a methodthereof.BACKGROUND OF THE INVENTION
[002] Background description includes information that may be useful in understandingthe present invention.
[003] Neurological disorders, including neurodegenerative, inflammatory, metabolic,oncological, and other brain-related conditions, arise from complex and dynamic interactionsamong diverse cellular and biochemical constituents of the nervous system. These diseasesoften involve multiple brain-cell populations such as neurons, astrocytes, and microglia, alongwith pathogenic biomolecules including amyloid-beta, tau, neurofibrillary tangles, and αsynuclein.The pathological microenvironments associated with these disorders evolve overextended periods and depend heavily on spatial and temporal interactions among the cellularand biochemical components. For example, Taylor et al. (Langmuir, 2003) introduced amicrofluidic multicompartment neuronal device designed to enable directed neurite growth andsoma-axon isolation, establishing the compartmental paradigm for neuronal studies.
[004] In vitro models that attempt to reproduce these disease-associated microenvironmentsfrequently rely on static culture systems, which are limited in their ability to replicatephysiological flow, chemical gradients, shear stresses, and the intricate crosstalk among braincell populations. Static co-culture approaches often fail to recreate the heterogeneousdistribution of pathogenic biomolecules, the fluid-dynamic conditions relevant to diseaseprogression, and the sustained interactions necessary for long-term culture or chronic diseasemodelling. As a result, these systems provide limited insight into disease initiation,propagation, or therapeutic response. In this context, Park et al. (Nature Neuroscience, 2018)demonstrated a 3D human triculture model incorporating neurons, astrocytes, and microgliathat recapitulates Alzheimer's disease hallmarks such as amyloid aggregation, tauphosphorylation, and neuroinflammation, although this platform typically lacks an on-chippassive pre-mixing stage and relies on external introduction of pathogenic factors.
[005] Microfluidic platforms have emerged as promising tools for modelling biologicalsystems due to their ability to manipulate small volumes, create controlled microenvironments,and integrate diverse biological components. Conventional microfluidic designs, however,frequently depend on external mechanical or electrical actuation to generate mixing orinteraction between multiple reagents or cell types. Such active mixing approaches addoperational complexity, may introduce undesirable shear stresses, and can be incompatible withshear-sensitive cells or long-term culture conditions. Many existing channel geometries do noteffectively promote passive diffusion or chaotic advection at low Reynolds numbers, makingit difficult to achieve homogeneous distribution of components without external intervention.Various studies, including Javaid et al. (Micromachines, 2018) and Jain & Unni (AIPAdvances, 2020), have analyzed serpentine, sinusoidal, and other passive mixer geometries,demonstrating improvements in diffusion-driven and chaotic-advection-based mixing withoutthe need for external mechanical or electrical actuation.
[006] Microfluidic fabrication techniques commonly employ polymeric materials such aspolydimethylsiloxane (PDMS) and utilize soft lithography or molding strategies to definechannel architectures. Bonding between polymeric layers and rigid substrates such as glasstypically requires additional treatments, including plasma activation. While additivemanufacturing has enabled the production of complex master molds, traditional fabricationworkflows often encounter limitations when creating intricate mixing geometries or large-areachambers suitable for extended cell culture. Furthermore, microfluidic devices must maintainshear stress levels compatible with viability of shear-sensitive cells, and chambers frequentlyrequire surface modifications or extracellular matrix coatings to support adhesion,proliferation, or long-term culture of neuronal and glial cell populations. For example, US7,419,822 B2 (Regents of the University of California) discloses microfluidic devicesincluding two or more microchambers interconnected by microgrooves that permit neuriteextension while restricting soma migration, enabling fluidic isolation, localized chemicalstimulation, and studies of axonal transport and synaptic connectivity. The architecture isexpressly configured to maintain separation between compartments and does not provide anin-line passive mixer or homogenization of multiple cell types and soluble factors prior to ashared interaction region.
[007] In disease-modelling applications, researchers often need to introduce multiplebiological or biochemical components through separate inlets to control their relativeproportions and to study their interactions under dynamic flow. However, independent flowrate regulation features are not universally available in standard microfluidic devices, andtrapped air in channels can disrupt microenvironment formation, impede perfusion, orcompromise cell viability. The ability to administer therapeutic agents through dedicated inletsduring or after microenvironment formation is also limited in many conventional systems,reducing their suitability for drug-screening or mechanistic studies. Similarly, US 11,939,560B2 (Draper Laboratory, Inc.) describes modular microfluidic cell-culture systemsincorporating integrated sensors and pump-driven perfusion for 3D culture.
[008] Monitoring or measuring cellular, biochemical, or physiological responses under shortterm or long-term culture conditions is essential for understanding disease progression and forevaluating candidate therapeutics. Yet, existing microfluidic systems often lack integrated orcompatible design characteristics that facilitate continuous observation, controlled delivery, ormaintenance of multi-component biological systems over extended periods.
[009] Thus, there is a need for microfluidic technologies capable of reliably manipulatingmultiple biological and biochemical components, promoting controlled passive mixing underlow-shear and low-Reynolds-number conditions, supporting long-term cell culture,accommodating disease-associated biomolecules, enabling independent flow regulation andtherapeutic delivery, and providing robust environments for modelling diverse biologicalmicroenvironments and analyzing their responses over time.OBJECTS OF THE INVENTION:
[0010] Some of the objects of the present disclosure, which at least one embodiment hereinsatisfies, are listed herein below.
[0011] A primary object of the present invention is to provide a microfluidic device that createsa realistic mixed biological microenvironment by enabling the introduction of multiplebiological or biochemical components through a plurality of inlets of a first chamber, passivelymixing the components within a microchannel having internal geometrical features, anddelivering the mixed components to a second chamber for controlled interaction or culture.
[0012] Another object of the present invention is to provide a microfluidic configuration thatallows neurons, astrocytes, and microglia to interact in the presence of disease-relatedbiomolecules, including amyloid-beta, neurofibrillary tangles, tau, or other pathologicalproteins, thereby supporting the modelling of neurodegenerative disorders underphysiologically relevant flow conditions.
[0013] Another object of the present invention is to provide a passive mixing architecture inwhich one or more internal geometrical features, including serpentine, zigzag, curvilinear, orother non-linear channel geometries, facilitate diffusion and chaotic advection-basedhomogenization of cells, particles, or therapeutic agents in the absence of external mechanicalor electrical mixing energy.
[0014] Another object of the present invention is to provide a platform that enables thecomponents to be uniformly mixed before entering the second chamber, such that the cells canadhere, proliferate, and establish co-cultures in a controlled microenvironment thatrecapitulates Alzheimer's-like or other disease-relevant conditions.
[0015] Another object of the present invention is to provide a device in which the first chamberoptionally includes flow-rate regulation features to independently modulate contributions fromeach inlet, thereby allowing precise control over proportional inputs of multiple cell types,disease-associated proteins, or therapeutic agents.
[0016] Another object of the present invention is to provide a fabrication approach employinga polymeric layer, optionally PDMS, bonded to a rigid substrate such as glass, wherein thepolymeric layer is produced by molding against a master mold manufactured through additivemanufacturing techniques.
[0017] Another object of the present invention is to provide a second chamber that isdimensioned and surface-modified to support long-term culture, cell adhesion, andextracellular-matrix deposition under continuous or intermittent perfusion, permitting real-timeobservation and analysis of cellular, biochemical, and physiological responses.
[0018] Another object of the present invention is to provide a microfluidic platform capable ofmaintaining shear stresses compatible with viability of shear-sensitive cells while enabling thestudy and modelling of neurodegenerative, inflammatory, metabolic, oncological, or othermicroenvironments, and further enabling the screening of therapeutic agents under controlledconditions.
[0019] Another object of the present invention is to provide a method for generating a mixedbiological microenvironment by introducing multiple components via respective inlets of thefirst chamber, directing said components through a microchannel having passive-mixinginternal geometrical features, delivering the mixed components to the second chamber, andculturing or maintaining them therein.
[0020] Another object of the present invention is to provide a method that additionally includesindependently controlling inlet flow rates, administering therapeutic agents through one ormore inlets during or after mixing, and observing or measuring short-term or long-termresponses within the second chamber.
[0021] These and other objects and advantages will become more apparent when referenceis made to the following description and accompanying drawings.SUMMARY OF THE INVENTION
[0022] This summary is provided to introduce concepts related to microfluidic technologies,and, more particularly, to a microfluidic device configured for generating a mixed biologicalmicroenvironment through passive mixing of multiple biological or biochemical componentswithin a microchannel having internal geometrical features and delivering the mixedcomponents to a downstream chamber for cellular interaction, co-culture, or disease-modelingapplications, and a method thereof. This summary is not intended to identify key features oressential features of the claimed subject matter, nor is it intended to be used to limit thescope of the claimed subject matter.
[0023] In an aspect of the present invention, a microfluidic device for generating a mixedbiological microenvironment is described. The device includes a first chamber, a secondchamber, and a microchannel. The first chamber having a plurality of inlets is configured toreceive respective biological or biochemical components. The second chamber is configuredto permit interaction or culture of the components. The microchannel is fluidicallyinterconnecting the first chamber and the second chamber. The microchannel includes one ormore internal geometrical features and is configured to promote passive mixing of thecomponents in the absence of externally applied mechanical or electrical mixing energy.
[0024] In at least one embodiment, the microchannel includes serpentine, curvilinear, zigzag,or other non-linear geometries, and the internal geometrical features include protrusions,constrictions, expansions, or combinations thereof to enhance passive mixing.
[0025] In at least one embodiment, the biological components include multiple cell populationsincluding neurons, astrocytes, microglia, or combinations thereof, optionally together withdisease-associated biomolecules including amyloid-beta, tau, neurofibrillary tangles, αsynuclein, or combinations thereof.
[0026] In at least one embodiment, the first chamber further includes flow-rate regulationfeatures configured to independently modulate contributions from each inlet.
[0027] In at least one embodiment, the device includes a polymeric layer bonded to a rigidsubstrate, the polymeric layer optionally having PDMS and the bonding optionally achievedby plasma activation.
[0028] In at least one embodiment, the polymeric layer is fabricated by molding against amaster mold produced by additive manufacturing.
[0029] In at least one embodiment, the second chamber is dimensioned and surface-modifiedto support long-term culture, cell adhesion, and extracellular-matrix deposition undercontinuous or intermittent perfusion.
[0030] In at least one embodiment, the microchannel and chamber dimensions are selected tomaintain shear stresses compatible with viability of shear-sensitive cells and to enablemodelling of neurodegenerative, inflammatory, metabolic, oncological, or othermicroenvironments, and optionally for screening therapeutic agents.
[0031] In another aspect of the present invention, a method for generating a mixed biologicalmicroenvironment in a microfluidic device is described. The method includes the step ofintroducing, through respective inlets of a first chamber, a plurality of biological or biochemicalcomponents. The method further includes the step of directing the components through amicrochannel having internal geometrical features configured to promote passive mixing in theabsence of external mechanical or electrical actuation. The method finally includes the step ofdelivering the mixed components to a second chamber and culturing or maintaining themtherein.
[0032] In at least one embodiment, the method further includes the step of independentlycontrolling inlet flow rates to regulate proportional contributions of the components,administering one or more therapeutic agents into at least one inlet during or after mixing, andobserving or measuring cellular, biochemical, or physiological responses within the secondchamber during short-term or long-term culture.
[0033] Various objects, features, aspects, and advantages of the inventive subject matterwill become more apparent from the following detailed description of preferredembodiments, along with the accompanying drawing figures in which like numeralsrepresent like components.BRIEF DESCRIPTION OF DRAWINGS:
[0034] The illustrated embodiments of the subject matter will be understood by referenceto the drawings, wherein like parts are designated by like numerals throughout. Theaccompanying drawings, which are incorporated in and constitute a part of this disclosure,illustrate exemplary embodiments and, together with the description, serve to explain thedisclosed principles. In the figures, the left-most digit(s) of a reference number identifies thefigure in which the reference number first appears. The same numbers are used throughout thefigures to reference like features and components. The following description is intended onlyby way of example and simply illustrates certain selected embodiments of devices,apparatus, systems, and methods that are consistent with the subject matter as claimedherein, wherein:
[0035] FIG. 1 illustrates a schematic view of a microfluidic device including a first chamberwith multiple inlets, a serpentine microchannel with zigzag geometrical features for passivemixing, and a second chamber for downstream interaction or culture, in accordance with anexemplary embodiment of the present disclosure;
[0036] FIG. 2 illustrates (a) a COMSOL simulation showing passive mixing of two fluidswithin a serpentine microchannel having zigzag structures, and (b) a correspondingconcentration color bar indicating mixing progression, in accordance with an exemplaryembodiment of the present disclosure;
[0037] FIG. 3 illustrates the mixing performance of the microfluidic device using three coloredfluids, red, yellow, and green, to visualize flow and blending through the serpentinemicrochannel, in accordance with an exemplary embodiment of the present disclosure;
[0038] FIG. 4 illustrates dimension particulars of a microfluidic device, in accordance with anexemplary embodiment of the present disclosure; and
[0039] FIG. 5 illustrates a flow diagram of a method for generating a mixed biologicalmicroenvironment by introducing components into the first chamber, passively mixing themthrough the microchannel, and delivering them to the second chamber, in accordance with anexemplary embodiment of the present disclosure.
[0040] The figures depict embodiments of the present subject matter for the purposes ofillustration only. A person skilled in the art will easily recognize from the followingdescription that alternative embodiments of the structures and methods illustrated hereinmay be employed without departing from the principles of the disclosure described herein.DETAILED DESCRIPTION OF THE INVENTION:
[0041] The following is a detailed description of embodiments of the disclosure depicted inthe accompanying drawings. The embodiments are in such detail as to clearly communicatethe disclosure. However, the amount of detail offered is not intended to limit the anticipatedvariations of embodiments; on the contrary, the intention is to cover all modifications,equivalents, and alternatives falling within the spirit and scope of the present disclosure asdefined by the appended claims.
[0042] While the embodiments of the disclosure are subject to various modifications andalternative forms, specific embodiments thereof have been shown by way of example in thefigures and will be described below. It should be understood, however, that it is not intendedto limit the disclosure to the particular forms disclosed, but on the contrary, the disclosure is tocover all modifications, equivalents, and alternatives falling within the scope of the disclosure.
[0043] The terms "comprises", "comprising", or any other variations thereof used in thedisclosure, are intended to cover a non-exclusive inclusion, such that a device, apparatus,system, or assembly that comprises a list of components does not include only thosecomponents but may include other components not expressly listed or inherent to such system,or apparatus, or assembly, or device. In other words, one or more elements in a system orapparatus or device proceeded by "comprises… a" does not, without more constraints, precludethe existence of other elements or additional elements in the system or apparatus or device.
[0044] The present disclosure relates to a microfluidic device configured for generating amixed biological microenvironment on a miniaturized and controllable platform. In variousembodiments, the microfluidic device includes a first chamber having a plurality of inletsconfigured to receive respective biological or biochemical components, a second chamberconfigured to permit downstream interaction or culture of the components, and a microchannelfluidically interconnecting the first chamber and the second chamber. The microchannelincludes one or more internal geometrical features, such as serpentine, curvilinear, or zigzagstructures, that are configured to promote passive mixing of the components in the absence ofexternally applied mechanical or electrical mixing energy.
[0045] In certain embodiments, the first chamber is configured to accommodate multiple cellpopulations introduced through the plurality of inlets. The components introduced may include,by way of example, neurons, astrocytes, microglia, or combinations thereof, together withdisease-associated biomolecules including amyloid-beta (Aβ), neurofibrillary tangles (NFTs),tau, α-synuclein, or combinations thereof. Accordingly, the first chamber provides an interfacethrough which distinct biological or biochemical inputs may be selectively introduced,optionally with independent flow-rate regulation to modulate proportional contributions fromeach inlet.
[0046] In operation, the disclosed microfluidic device facilitates passive and efficient mixingof the introduced biological components as they flow through the microchannel. The serpentinegeometry and integrated zigzag internal features of the microchannel are dimensioned andarranged to enhance diffusion and promote chaotic advection, thereby enabling effectivehomogenization of cells, particles, soluble factors, or therapeutic agents without requiringexternal actuation. As the mixture progresses along the channel length, the interacting flowsensure that, by the time the composite fluid reaches the second chamber, the components aresubstantially uniformly distributed. In certain preferred embodiments of the present disclosure,the microchannel interconnecting the first chamber and the second chamber is implemented asa serpentine channel incorporating zigzag, curved, or otherwise non-linear geometrical featuresconfigured to promote passive mixing of the introduced components.
[0047] In some embodiments, the second chamber is dimensioned and surface-modified tosupport long-term cell adhesion, growth, proliferation, and extracellular-matrix deposition.Within this chamber, the mixed biological components can engage in controlled interactionsunder physiologically relevant flow conditions. The presence of Alzheimer's-associatedbiomolecules, such as amyloid-beta or neurofibrillary tangles, in combination with neurons,astrocytes, and microglia, enables the device to recreate an Alzheimer's-like microenvironmenton-chip. This configuration permits real-time observation, measurement, and analysis ofcellular, biochemical, or physiological responses arising from exposure to pathogenic stimuli.
[0048] The microfluidic device may include a polymeric layer bonded to a rigid substrate, thepolymeric layer optionally including polydimethylsiloxane (PDMS), and the bondingoptionally achieved by plasma activation. In certain embodiments, the polymeric layer isfabricated by molding against a master mold produced by additive manufacturing, therebyenabling rapid, reproducible, and high-fidelity fabrication of serpentine and zigzagmicrochannel geometries. The dimensions of the microchannel and chambers may be selectedto maintain shear stresses compatible with the viability of shear-sensitive cell types and toenable modelling of neurodegenerative, inflammatory, metabolic, oncological, or relatedmicroenvironments.
[0049] The disclosed microfluidic architecture further supports a method for generating amixed biological microenvironment. The method includes introducing, through respectiveinlets of the first chamber, a plurality of biological or biochemical components; directing thecomponents through the microchannel having internal geometrical features configured topromote passive mixing; and delivering the mixed components to the second chamber forsubsequent culture or maintenance. The method may additionally include independentlycontrolling inlet flow rates, administering therapeutic agents during or after mixing, andobserving or quantifying cellular or biochemical responses over short-term or long-termculture.
[0050] For better understanding, one or more embodiments of the present invention shallbe described with respect to the earlier-mentioned drawings.
[0051] FIG. 1 illustrates a schematic representation (100) of a microfluidic device configuredfor generating a mixed biological microenvironment in accordance with an exemplaryembodiment of the present disclosure. As shown in FIG. 1, the device includes a plurality ofinlets (102) leading into a first chamber (104), a serpentine microchannel (106) fluidicallyinterconnecting the first chamber (104) and a second chamber (108), and one or more outlets(110) positioned downstream of the second chamber (108) for removal or recirculation of fluid.The structural arrangement is configured to permit introduction, passive mixing, andsubsequent interaction or culture of biological or biochemical components within the device.
[0052] In the embodiment illustrated in FIG. 1, the first chamber (104) includes three inlets(102), each configured to receive a respective biological or biochemical component such asneuronal cells, astrocyte cells (116), microglial cells (112), or disease-associated biomolecules,for example amyloid-beta, tau, neurofibrillary tangles (NFTs) introduced along with neurons(114), or α-synuclein. The geometry of the first chamber (104) may further include optionalflow-rate regulation features configured to independently modulate the volumetric flowcontributions from each inlet (102), thereby enabling precise control of the relative proportionsof the introduced biological components. Alternative embodiments may incorporate two, four,or more inlets depending on the required degree of compositional complexity for the resultingmixed microenvironment.
[0053] The microchannel (106), which fluidically interconnects the first chamber (104) andthe second chamber (108), includes one or more internal geometrical features configured topromote passive mixing of the introduced components in the absence of externally appliedmechanical or electrical mixing energy. In the embodiment shown, the microchannel (106) isimplemented as a serpentine channel having zigzag, curved, or otherwise non-lineargeometries. These geometrical features, including optional protrusions, constrictions, andexpansions, enhance diffusion and induce chaotic advection under laminar-flow and lowReynolds-number conditions, enabling progressive homogenization of the biological orbiochemical components as they traverse the microchannel (106). In alternative embodiments,the microchannel may adopt sinusoidal, spiral, coil-like, or hybrid geometries, each providingcomparable passive mixing functionality.
[0054] As the components flow along the microchannel (106), the repeated curvature andinternal features of the serpentine geometry cause transverse displacement and folding of fluidstreamlines, thereby improving mixing efficiency without the need for pumps, actuators, orexternal energy input. This passive-mixing mechanism is particularly advantageous forbiological applications involving shear-sensitive cells, as the channel and chamber dimensionsmay be selected to maintain shear stress levels compatible with viability and physiologicalbehavior. In certain embodiments, the microchannel (106) may be dimensioned to supportReynolds numbers less than approximately 1, promoting diffusion-assisted mixing suitable forneuronal, glial, or biochemical components.
[0055] The second chamber (108), positioned downstream of the microchannel (106), isconfigured to receive the homogenized mixture of biological or biochemical components andpermit their interaction, co-culture, adhesion, proliferation, or long-term maintenance. In theembodiment depicted in FIG. 1, the second chamber (108) can support co-culture of neurons,astrocytes, and microglia in the presence of pathogenic biomolecules such as NFTs andamyloid-beta, enabling formation of disease-like microenvironments such as Alzheimer'srelated, inflammatory, or neurodegenerative states. The second chamber (108) may optionallyinclude surface-modification coatings that promote cell adhesion or extracellular-matrixdeposition, and may operate under continuous or intermittent perfusion through outlet (110).
[0056] In certain embodiments, the microfluidic device includes a polymeric layer, optionallyPDMS, bonded to a rigid substrate such as glass, wherein bonding may be achieved by plasmaactivation. The polymeric layer may be fabricated by molding against a master mold producedusing additive manufacturing techniques, enabling precise formation of the serpentinemicrochannel (106) and the chambers (104, 108). Alternative fabrication techniques mayinclude soft lithography, laser micromachining, hot embossing, or hybrid multilayermicrofabrication depending on the desired resolution, material properties, and applicationrequirements.
[0057] Although FIG. 1 depicts a brain-on-chip implementation involving neurons, astrocytes,microglia, and Alzheimer's-related biomolecules, alternative embodiments may utilize anycombination of biological or biochemical components including stem cells, immune cells,cancer cells, metabolic factors, inflammatory mediators, viral particles, or therapeutic agents.Likewise, the device may be used to model microenvironments relevant to neurodegenerative,inflammatory, metabolic, oncological, infectious, or pharmacological research, and mayfurther serve as a screening platform for evaluating therapeutic compounds introduced throughone or more of the inlets (102).
[0058] FIG. 2 illustrates a COMSOL (a computer based tool) simulation (200) for evaluatingthe passive mixing performance of the microchannel (206, corresponding to 106 of FIG. 1)fluidically interconnecting the first chamber (204, corresponding to 104 of FIG. 1) and thesecond chamber (208, corresponding to 108 of FIG. 1). In the simulation, two representativefluids were introduced through respective inlets (202, corresponding to 102 of FIG. 1) to mimicthe behavior of distinct biological or biochemical components as they traverse themicrochannel (206). The simulation demonstrates the effect of internal geometrical features,including serpentine and zigzag structures, on diffusion- and advection-driven mixing.
[0059] As shown in FIG. 2(a), the fluids entering the first chamber (204) progress through theserpentine microchannel (206), where repeated curvature, directional changes, and embeddedgeometrical features promote transverse displacement and stretching of fluid streamlines. Thisaction facilitates homogenization of the fluid streams in the absence of externally appliedmechanical or electrical mixing energy, consistent with the passive-mixing configuration. Thesimulation illustrates that even under laminar flow conditions, the internal geometrical featuresgenerate sufficient chaotic advection to ensure progressive blending of the components priorto entry into the second chamber (208) having outlets (210).
[0060] FIG. 2(b) presents a color bar (212) corresponding to concentration levels within themicrochannel (206). Dark blue represents regions of low concentration, dark red representsregions of high concentration, and intermediate shades of light blue, green, yellow, and orangeindicate gradual blending of the fluids during passive mixing. The simulation confirms that bythe time the fluids reach the second chamber (208), a substantially uniform concentrationdistribution is achieved, ensuring consistent exposure of downstream cells or biochemicalcomponents. This outcome demonstrates that the microchannel geometry effectively supportsmixing of multiple components introduced through the first chamber (204) without requiringactive actuation.
[0061] The simulation environment further allows parametric analysis of flow rates at eachinlet (202), channel curvature, zigzag amplitude, and microchannel cross-sectional dimensionsto optimize mixing efficiency while maintaining shear stresses compatible with the viability ofshear-sensitive biological components. Such parametric variations may include independentmodulation of inlet flow rates, alternative serpentine geometries, or the incorporation ofprotrusions, constrictions, and expansions within the microchannel (206) to enhance diffusionand advection-driven mixing.
[0062] Although FIG. 2 illustrates the mixing of two representative fluid components,alternative embodiments may simulate multiple fluid streams to model interactions amongneurons, astrocytes, microglia, or other cell populations in combination with disease-associatedbiomolecules such as amyloid-beta, tau, or neurofibrillary tangles (NFTs). Such simulationsprovide predictive insights into fluidic behavior within the microchannel (206), facilitatingexperimental design and optimization of microfluidic devices for modeling neurodegenerative,inflammatory, metabolic, or oncological microenvironments.
[0063] In addition to evaluating concentration distribution, the COMSOL simulation allowsvisualization of temporal mixing dynamics, enabling assessment of residence time and mixingefficiency over the length of the serpentine microchannel (206). This supports informeddecisions regarding channel length, number of serpentine turns, and internal feature dimensionsto achieve uniform mixing before delivery to the second chamber (208), thereby ensuringreproducible formation of a mixed biological microenvironment suitable for downstream coculture or analytical studies.
[0064] FIG. 3 illustrates an experimental evaluation (300) of the microfluidic device (100, FIG.1) configured to generate a mixed biological microenvironment. In this exemplaryembodiment, three distinct aqueous fluids, red, yellow, and green, were introduced through theplurality of inlets (202 of FIG. 2, corresponding to 102 of FIG. 1) of the first chamber (204 ofFIG. 2, corresponding to 104 of FIG. 1). The experimental setup allows direct visualization offlow behavior, mixing profiles, and transport dynamics through the microchannel (206 of FIG.2, corresponding to 106 of FIG. 1) and into the second chamber (208 of FIG. 2, correspondingto 108 of FIG. 1).
[0065] As the fluids traverse the microchannel (206), which includes internal geometricalfeatures including serpentine and zigzag structures, progressive blending occurs due totransverse displacement, stretching of fluid elements, and advection-driven mixing, consistentwith the passive-mixing function. By monitoring the evolution of fluid colors, the experimentalstudy provides empirical validation of the mixing efficiency predicted in the COMSOLsimulations of FIG. 2, confirming that the microchannel (206) achieves homogenizationwithout externally applied mechanical or electrical energy.
[0066] During the experiment, the initially separate red, yellow, and green fluid streamsgradually merge, forming an intermediate shade (302) indicative of substantial mixing. Thiscolor transition demonstrates that the microchannel dimensions, internal feature design, andoverall serpentine path effectively promote uniform distribution of components prior todelivery to the second chamber (208). The results further substantiate that variations in inletflow rates and channel geometry can be used to optimize residence time and mixing for a rangeof biological or biochemical components, including multiple cell populations such as neurons,astrocytes, and microglia, optionally combined with disease-associated biomolecules.
[0067] The experimental evaluation also verified operational reliability of the microfluidicdevice under continuous flow conditions. No leakage or channel blockage was observed, andthe color mixing profiles were reproducible across repeated trials. These observationsdemonstrate that the polymeric layer, optionally including PDMS and bonded to a rigidsubstrate, provides structural stability while maintaining functional microchannel geometries.
[0068] This experimental approach provides a direct method for assessing transport dynamicsand passive-mixing efficiency in microfluidic devices intended for generating mixed biologicalmicroenvironments, serving as a precursor for studies involving actual biological orbiochemical components. For example, cells introduced through the inlets (202) can bemonitored for uniform exposure to co-factors or therapeutic agents, enabling controlled coculture in the second chamber (208). The observed formation of the intermediate shade (302)serves as a proxy for uniform component distribution and demonstrates that the deviceeffectively supports creation of a mixed microenvironment suitable for downstream biologicalanalysis or therapeutic screening.
[0069] In certain preferred embodiments, the microchannel extending between the firstchamber and the second chamber is formed as a serpentine channel incorporating zigzag,curved, or other non-linear geometrical features that enhance passive mixing of the introducedcomponents. The repeated directional changes and embedded micro-scale projections generatelocalized variations in flow velocity, thereby promoting chaotic advection within the channel.These geometrical features increase the effective fluid path length while maintaining a compactdevice footprint, enabling controlled residence time for biochemical or cellular processes. Insome embodiments, the zigzag structures further create alternating constriction-expansionregions that disrupt laminar flow profiles and improve mixing efficiency without externalactuation. Together, the serpentine layout and internal features provide a robust, energy-freemechanism for homogenizing multiple input streams prior to entry into the second chamber.
[0070] FIG. 4 illustrates dimension particulars (400) of a microfluidic device, in accordancewith an embodiment of the present disclosure. In an exemplary embodiment, the microfluidicdevice includes a compact, layered structure formed from a polymeric material such aspolydimethylsiloxane (PDMS) bonded to a rigid substrate, for example a glass slide. Thedevice includes a first chamber, a serpentine microchannel embedded with internal zigzaggeometrical features, and a second chamber for downstream culture or collection, collectivelyarranged within an overall device footprint measuring approximately 24.5 mm in length and0.3 mm in height. The configuration is designed to manipulate, mix, and process microscalefluid volumes in a controlled manner without requiring externally applied mechanical orelectrical mixing energy.
[0071] The first chamber (inlet-side chamber) is dimensioned to facilitate initial introductionand stabilization of fluid streams prior to entry into the microchannel. In one embodiment, thefirst chamber has a length of approximately 5 mm and a width of approximately 2 mm. Aplurality of inlets is provided upstream of this chamber, each inlet including a circular porthaving a diameter of approximately 1.6 mm. These inlets transition into initial channelsegments having a width of approximately 0.8 mm, enabling independent delivery of distinctbiological or biochemical components into the device for subsequent mixing or processing.
[0072] The serpentine microchannel extends downstream of the first chamber and functions asthe primary region for passive mixing, reaction, or fluid conditioning. The major serpentinepathway includes repeating lateral and vertical turns, each segment measuring approximately4 mm horizontally between bends and 1.5 mm vertically across turns. Within this serpentinepath, the device incorporates embedded zigzag microstructures configured to promote chaoticadvection, enhance transverse mixing, and increase residence time. In one embodiment, thefundamental straight-channel width (parameter a) is approximately 0.5 mm, with each zigzagprotrusion having a width (parameter c) of approximately 0.2 mm, a projection length(parameter d) of approximately 0.3 mm, and an inter-projection spacing (parameter e) ofapproximately 0.25 mm. Straight intermediate channel sections between zigzag arrays mayhave a length (parameter b) of approximately 4 mm. These features collectively inducealternating constriction-expansion events that disrupt laminar flow profiles and generateefficient passive mixing.
[0073] Downstream of the serpentine microchannel, the device includes a second chamberconfigured to receive the fully or partially mixed fluid stream. In one embodiment, the secondchamber has a length of approximately 3 mm and a width of approximately 6 mm, providing adefined area suitable for fluid collection, biochemical reactions, or cellular culture dependingon the intended application. The chamber may optionally contain surface-modified regions tosupport adhesion and long-term maintenance of shear-sensitive cell types. A pair of outletchannels extends from the second chamber, each outlet terminating in a circular port having adiameter of approximately 1.6 mm, permitting removal, sampling, or redirection of processedfluids.
[0074] The device geometry, including the dimensions of the serpentine and zigzag features,is selected to achieve predetermined mixing efficiency, fluid residence time, shear stressdistribution, and flow uniformity across a wide range of inlet conditions. The use of PDMS andsoft-lithographic or additive-manufacturing-assisted molding enables precise reproduction ofthese microstructures with high fidelity. Alternative embodiments may adjust channel widths,projection depths, chamber size, or inlet / outlet configuration to tailor the device for specificapplications such as chemical reaction monitoring, point-of-care diagnostics, cell-cellinteraction assays, or modeling of disease microenvironments.
[0075] FIG. 5 illustrates a method flow diagram (500) for generating a mixed biologicalmicroenvironment in a microfluidic device (100, FIG. 1) in accordance with an exemplaryembodiment of the present disclosure. The method includes the steps of introducing (502) aplurality of biological or biochemical components through respective inlets of a first chamber,directing (504) the introduced components through a microchannel having internal geometricalfeatures configured to promote passive mixing in the absence of externally applied mechanicalor electrical actuation, and delivering (506) the mixed components to a second chamber forsubsequent culture, maintenance, or interaction.
[0076] In the first step (502), the method includes introducing biological components such asneurons, astrocytes, microglia, or combinations thereof, optionally together with biochemicalor disease-associated biomolecules including amyloid-beta, tau, neurofibrillary tangles, or αsynuclein. Each component may be supplied through a dedicated inlet that enables controlledflow delivery to the first chamber. The method thus facilitates selective pre-conditioning,proportional dosing, or temporal staggering of component inputs when required for specificbiological modeling applications.
[0077] In the second step (504), the introduced components are directed through themicrochannel of the device, the microchannel including serpentine, zigzag, curvilinear, or othernon-linear internal geometrical features configured to promote passive mixing. As thecomponents traverse the microchannel, stretching, folding, and redistribution of fluid streamsoccur, enhancing diffusion-driven and advection-driven mixing without the need for pumps,stirrers, magnetic beads, or externally applied electrical fields. In certain embodiments,protrusions, constrictions, expansions, or combinations thereof may be incorporated to increasemixing efficiency, modulate shear exposure, or adjust residence time depending onexperimental requirements.
[0078] In the final step (506), the mixed components are delivered to the second chamber,which is dimensioned and surface-modified to support cell adhesion, extracellular-matrixdeposition, and long-term co-culture under continuous or intermittent perfusion, consistentwith the device features described above. Upon delivery, the components may interact,proliferate, or respond to introduced pathological factors, thereby forming a mixed biologicalmicroenvironment suitable for evaluating neurodegenerative, inflammatory, metabolic,oncological, or therapeutic processes. In certain embodiments, the mixed components may bemaintained in static, perfused, or pulsatile flow modes to replicate physiological conditions ofinterest.
[0079] In at least one embodiment, the method further includes the step of independentlycontrolling inlet flow rates to regulate proportional contributions from each component. Suchflow-rate modulation may be achieved using syringe pumps, gravity-fed reservoirs, hydrostaticpressure differences, or integrated flow-resistive elements associated with the inlets. Precisecontrol of inlet ratios enables creation of tunable microenvironments with defined cell-to-cellor cell-to-biomolecule concentrations, facilitating disease modeling or drug-response studies.
[0080] The method can also include administering one or more therapeutic agents into at leastone of the inlets either during or after the mixing process. For example, neuroprotectivecompounds, anti-inflammatory drugs, anti-amyloid agents, or gene-editing constructs may beintroduced through a dedicated inlet to assess their effects on the mixed cellular populationsupon arrival at the second chamber. In certain embodiments, the therapeutic administrationmay be pulsed, sustained, or gradient-based depending on study requirements.
[0081] Following delivery to the second chamber, the method may include observing ormeasuring cellular, biochemical, or physiological responses during short-term or long-termculture. Such observations may be conducted using bright-field microscopy, fluorescenceimaging, immunostaining, electrophysiological recordings, or biochemical assays. Forexample, researchers may measure neuronal viability, microglial activation, astrocyticreactivity, or accumulation of disease-associated aggregates over time.
[0082] Alternative embodiments may incorporate additional steps such as temperatureregulation, flow-rate cycling, solution exchange, sampling of effluent at the outlet, orincorporation of biomimetic extracellular-matrix gels within the second chamber to providemore physiologically relevant culture conditions. Furthermore, the method can be adapted fornon-neurological applications by modifying the introduced components, includingincorporation of cancer cells, immune cells, stem cells, or metabolic biomarkers, therebyextending the utility of the device to a wide range of microenvironmental studies.
[0083] The method depicted in FIG. 5 therefore provides a robust and versatile framework forgenerating a mixed biological microenvironment in a microfluidic device, enablingreproducible passive mixing, controlled component delivery, and physiologically relevantculture conditions without the need for complex or energy-intensive mixing mechanisms.
[0084] The present invention offers the following major technical advantages:- Enhanced Passive Mixing: The serpentine microchannel incorporating zigzag or nonlinear geometrical features induces chaotic advection and repeated constriction-expansion cycles, enabling efficient passive mixing without external mechanical orelectrical energy.- Reduced Device Footprint: The compact serpentine layout increases effective channellength within a limited planar area, allowing prolonged residence time and reactionpathways without increasing the device size.- Improved Microenvironment Control: Independent inlets allow precise regulation ofthe proportional contribution of each biological or biochemical component, enablingreproducible creation of complex, gradient-based, or heterogeneousmicroenvironments.- Compatibility With Shear-Sensitive Cells: Optimized channel and chamber dimensionsmaintain shear stresses within biologically tolerable ranges, supporting the viability ofdelicate cell types such as neurons and astrocytes during perfusion.- Enhanced Visualization and Monitoring: The transparent PDMS-glass constructionprovides optical accessibility for real-time imaging of flow behavior, mixing profiles,and cellular responses.- Stable Long-Term Cell Culture: The second chamber is dimensioned and surfacemodifiable to support adhesion, extracellular matrix deposition, and extended cultureperiods, enabling long-term biological studies.- Versatile Biological Modeling: The device supports multiple cell populations anddisease-associated biomolecules, making it suitable for modeling neurodegenerative,inflammatory, metabolic, oncological, and other pathophysiological conditions.- High Compatibility With Therapeutic Screening: The architecture allows introductionof therapeutic agents through any inlet during or after mixing, enabling controlled drugexposure and quantitative assessment of treatment responses.- Low Cost and Rapid Fabrication: PDMS molding against an additively manufacturedmaster mold enables rapid prototyping and low-cost fabrication suitable for researchlaboratories and customizable assays.- Scalable and Modular Design: The microchannel geometry and chamber layout can bereadily scaled or modified to adapt to various applications, including organ-on-chipsystems, chemical reactions, or point-of-care diagnostics.
[0085] It is understood that any specific order or hierarchy of blocks in the processes disclosedis an illustration of example approaches. Based upon design preferences, it is understood thatthe specific order or hierarchy of blocks in the processes may be rearranged, or that allillustrated blocks be performed. Any of the blocks may be performed simultaneously. In oneor more implementations, multitasking and parallel processing may be advantageous.Moreover, the separation of various system components in the implementations describedabove should not be understood as requiring such separation in all implementations, and itshould be understood that the described program components and systems can generally beintegrated together in a single software product or packaged into multiple software products.
[0086] Although embodiments for the present subject matter have been described in languagespecific to package features, it is to be understood that the present subject matter is notnecessarily limited to the specific features described. Rather, the specific features and methodsare disclosed as embodiments for the present subject matter. Numerous modifications andadaptations of the system / device of the present invention will be apparent to those skilled inthe art, and thus it is intended by the appended claims to cover all such modifications andadaptations which fall within the scope of the present subject matter.
Claims
1. A microfluidic device for generating a mixed biological microenvironment, comprising: a first chamber having a plurality of inlets configured to receive respective biological or biochemical components; a second chamber configured to permit interaction or culture of the components; and a microchannel fluidically interconnecting the first chamber and the second chamber, wherein the microchannel comprises one or more internal geometrical features configured to promote passive mixing of the components in the absence of externally applied mechanical or electrical mixing energy.
2. The device as claimed in claim 1, wherein the microchannel comprises serpentine, curvilinear, zigzag, or other non-linear geometries, and the internal geometrical features comprise protrusions, constrictions, expansions, or combinations thereof to enhance passive mixing.
3. The device as claimed in claim 1, wherein the biological components comprise multiple cell populations including neurons, astrocytes, microglia, or combinations thereof, optionally together with disease-associated biomolecules including amyloid-beta, tau, neurofibrillary tangles, αsynuclein, or combinations thereof.
4. The device as claimed in claim 1, wherein the first chamber further comprises flow-rate regulation features configured to independently modulate contributions from each inlet.
5. The device as claimed in claim 1, wherein the device comprises a polymeric layer bonded to a rigid substrate, the polymeric layer optionally comprising PDMS and the bonding optionally achieved by plasma activation.
6. The device as claimed in claim 5, wherein the polymeric layer is fabricated by molding against a master mold produced by additive manufacturing.
7. The device as claimed in claim 1, wherein the second chamber is dimensioned and surfacemodified to support long-term culture, cell adhesion, and extracellular-matrix deposition under continuous or intermittent perfusion.
8. The device as claimed in claim 1, wherein the microchannel and chamber dimensions are selected to maintain shear stresses compatible with viability of shear-sensitive cells and to enable modelling of neurodegenerative, inflammatory, metabolic, oncological, or other microenvironments, and optionally for screening therapeutic agents.
9. A method for generating a mixed biological microenvironment in a microfluidic device, comprising: introducing (502), through respective inlets of a first chamber, a plurality of biological or biochemical components; directing (504) the components through a microchannel having internal geometrical features configured to promote passive mixing in the absence of external mechanical or electrical actuation; and delivering (506) the mixed components to a second chamber and culturing or maintaining them therein.
10. The method as claimed in claim 9, further comprising independently controlling inlet flow rates to regulate proportional contributions of the components, administering one or more therapeutic agents into at least one inlet during or after mixing, and observing or measuring cellular, biochemical, or physiological responses within the second chamber during short-term or long-term culture.
